A three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) has resulted in a new AI-driven drug discovery method that could ...
Scientists at the University of California, San Francisco (UCSF), have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases—from Parkinson’s ...
Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, ...
In a move that could reshape drug discovery, researchers at Harvard Medical School (HMS) have designed an artificial intelligence (AI) model they say is capable of identifying treatments that reverse ...
TORONTO--(BUSINESS WIRE)--Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three ...
Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results